Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation.

ABSTRACT: Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm, and its incidence has doubled over the past two decades owing to increasing risk factors. Despite surveillance, most HCC cases are diagnosed at advanced stages and can only be treated using transarterial chemo-embolization (TACE) or systemic therapy. TACE failure may occur with incidence reaching up to 60% of cases, leaving patients with a financial and emotional burden. Radiomics has emerged as a new tool capable of predicting tumor response to TACE from pre-procedural computed tomography (CT) studies. This data report defines the HCC-TACE data collection of confirmed HCC patients who underwent TACE and have pre- and post-procedure CT imaging studies and available treatment outcomes (time-to-progression and overall

SUBMITTER: Moawad AW 

PROVIDER: S-EPMC9849450 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature